Welch Allyn gets class I stamp for AED (automated external defibrillator) recall
This article was originally published in Clinica
The US FDA has assigned a class I designation - the most serious level - to Welch Allyn's worldwide recall of some 1,722 automated external defibrillators (AEDs), devices used to help resuscitate patients who have suffered a heart attack.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.